Utilization of Stimuli-Responsive Biomaterials in the Formulation of Cancer Vaccines

Immunology research has focused on developing cancer vaccines to increase the number of tumor-specific effector cells and their ability to fight cancer over the last few decades. There is a lack of professional success in vaccines compared to checkpoint blockade and adoptive T-cell treatment. The va...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Arun Kumar, Malviya, Rishabha, Prajapati, Bhupendra, Singh, Sudarshan, Goyal, Priyanshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219237/
https://www.ncbi.nlm.nih.gov/pubmed/37233357
http://dx.doi.org/10.3390/jfb14050247

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219237/
https://www.ncbi.nlm.nih.gov/pubmed/37233357
http://dx.doi.org/10.3390/jfb14050247

Ejemplares similares